Development of hormone insensitive disease

It’s still a major challenge to understand how prostate tumours become insensitive to testosterone signalling (a state known as Castrate Resistant Prostate Cancer, or hormone relapsed prostate cancer). At this stage conventional hormone based treatments no longer work, but if we could prevent cancers from becoming resistant to hormone therapies, we could prolong the time these treatments are effective for.